- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Acute myeloid leukemia (AML)
Total 28692 results
-
PTC TherapeuticsTerminatedLeukemia, Myeloid, Acute | AMLUnited States
-
University Hospital, CaenUnknown
-
Institute of Hematology & Blood Diseases HospitalSuspended
-
GlycoMimetics IncorporatedActive, not recruitingAcute Myeloid LeukemiaUnited States, Canada, Spain, Australia, Netherlands, France, Ireland, Italy, United Kingdom
-
Zhongnan HospitalRecruitingUCB (Cord Blood) Microtransplantation in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)China
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingTreatment-naive or Relapsed or Refractory Acute Myeloid Leukemia (AML)China
-
King Fahad Medical CityUnknown
-
Sumitomo Pharma America, Inc.TerminatedAcute Myeloid Leukemia (AML)United States
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | Multiple Myeloma (MM) | Non-Hodgkin Lymphoma (NHL)Belgium, Italy, Korea, Republic of, Hong Kong, Israel, Finland, Spain, Japan, United States
-
M.D. Anderson Cancer CenterRecruiting
-
University of UlmCompletedAcute Myeloid Leukemia (AML)Germany, Austria
-
University of California, Los AngelesRecruitingCardiovascular Diseases | Atherosclerosis | Arterial Occlusion | HematomaUnited States
-
University of California, Los AngelesCompletedCardiovascular Diseases | Arterial Occlusion | HematomaUnited States
-
Cardiff UniversityCancer Research UKUnknownMyelodysplastic Syndrome | Acute Myeloid LeukaemiaDenmark, United Kingdom
-
Aeglea BiotherapeuticsCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States, Canada
-
Mateon TherapeuticsUnknownMyelodysplastic Syndromes | Acute Myelogenous LeukemiaUnited States
-
Assiut UniversityUnknown
-
Guangdong Ruishun Biotech Co., LtdFirst Affiliated Hospital of Zhejiang UniversityRecruiting
-
University of UlmCompletedAcute Myeloid Leukemia (AML)Germany, Austria
-
Fujifilm Pharmaceuticals U.S.A., Inc.CompletedAML | MDS | CMMLUnited States
-
Zhejiang UniversityHangzhou Qihan Biotech Co.,Ltd.Recruiting
-
Sichuan Baili Pharmaceutical Co., Ltd.RecruitingRelapsed/Refractory Acute Myeloid Leukemia (R/R AML)China
-
University Hospital, BordeauxCompleted
-
Sherif FaragWithdrawn
-
Rigshospitalet, DenmarkRecruiting
-
GWT-TUD GmbHRecruiting
-
French Innovative Leukemia OrganisationAcute Leukemia French AssociationCompletedRelapsed Adult AML | Refractory AML | FLT3-TKD Mutation | FLT3-ITDFrance
-
French Innovative Leukemia OrganisationAcute Leukemia French AssociationNot yet recruiting
-
Nantes University HospitalRecruiting
-
AbbVieMerck Sharp & Dohme LLCTerminatedCancer - Acute Myeloid LeukemiaUnited States, Australia, Spain
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); MacroGenicsRecruiting
-
Masonic Cancer Center, University of MinnesotaRecruitingMyelodysplastic Syndromes | Leukemia | Previously Treated Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Childhood Acute Myeloid Leukemia in Remission | Childhood Acute Lymphoblastic Leukemia in Remission | Recurrent Childhood Acute Myeloid Leukemia | Secondary Myelodysplastic Syndrome and other conditionsUnited States
-
Richard Stone, MDMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's HospitalActive, not recruitingRAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDSAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedAcute Myeloid Leukemia | Higher Risk Myelodysplastic SyndromeUnited States
-
Masonic Cancer Center, University of MinnesotaUniversity of MinnesotaWithdrawnSecondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Treatment-Related Acute Myeloid Leukemia | High-Risk Acute Myeloid LeukemiaUnited States
-
Dana-Farber Cancer InstituteNational Institutes of Health (NIH); Brigham and Women's HospitalCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterWake Forest UniversityTerminatedChronic Myelomonocytic Leukemia | Acute Myelogenous LeukemiaUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruiting
-
Technische Universität DresdenAbbVieActive, not recruitingRelapsed Adult AML | Refractory AMLGermany
-
GlaxoSmithKlineActive, not recruitingLung Cancer, Non-Small CellArgentina, Korea, Republic of, Spain, Finland, Taiwan, Italy, Netherlands, Germany, Australia, Mexico, United States, Belgium, Canada, United Kingdom, Greece, Romania, Sweden, Russian Federation, Poland, France, Brazil, Japan, Thailand and more
-
Institut de Recherches Internationales ServierActive, not recruitingLeukemia, Myeloid, Acute | Untreated AML | Newly Diagnosed Acute Myeloid Leukemia (AML) | AML Arising From Myelodysplastic Syndrome (MDS)Spain, United States, France, Korea, Republic of, Taiwan, Australia, Canada, Germany, China, Italy, Austria, Czechia, Poland, Japan, United Kingdom, Russian Federation, Netherlands, Brazil, Israel, Mexico
-
French Innovative Leukemia OrganisationAcute Leukemia French AssociationNot yet recruiting
-
Medical College of WisconsinNot yet recruitingRelapsed Adult AML | Refractory AMLUnited States
-
Precigen, IncRecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
University of RochesterRecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Masonic Cancer Center, University of MinnesotaIncyte CorporationCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Myeloid and Monocytic LeukemiaUnited States
-
University of LouisvilleWithdrawnAcute Myelogenous LeukemiaUnited States
-
University of Kansas Medical CenterWithdrawn
-
Technische Universität DresdenBayerCompleted